GB00BYMT0J19
© BusinessWire
25.11.2025
LIVN
LISTED
NASDAQ
LivaNova to Present at Piper Sandler Healthcare Conference in December
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Alex Shvartsburg, Chief Financial Officer, will present a general business update during a fireside chat at the Piper Sandler 37th Annual Healthcare Conference in New York City. The presentation will take place on Tues., Dec. 2, at 1:30 p.m. Eastern Stan...
Themefolio
Profiler
Peergroup
© BusinessWire
24.11.2025
LIVN
LISTED
NASDAQ
LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) assigned VNS Therapy™, a LivaNova neuromodulation treatment for patients 4 years of age and older with Drug-Resistant Epilepsy (DRE) and focal seizures, to New Technology Ambulatory Payment Clas...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2025
LIVN
LISTED
NASDAQ
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today hosted its 2025 Investor Day and presented its comprehensive strategic roadmap and long-range financial plan.
“We are confident in our ability to deliver on the targets we outlined today. LivaNova’s talented team is focused on a revitalized innovation strategy and op...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
05.11.2025
LIVN
LISTED
NASDAQ
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the third quarter ended September 30, 2025 and raised full-year 2025 guidance.
Financial Summary and Highlights(1)
Third-quarter revenue of $357.8 million increased 12.5% on a reported basis, 11.0% on a constant-currency basis, and 12.5% on an o...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
23.10.2025
LIVN
LISTED
NASDAQ
LivaNova to Present at Wolfe Research Healthcare Conference in November
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Vladimir Makatsaria, Chief Executive Officer, and Alex Shvartsburg, Chief Financial Officer, will present a general business update during a fireside chat at the Wolfe Research Healthcare Conference 2025 in New York City. The presentation will take place...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
LIVN
LISTED
NASDAQ
LivaNova to Announce Third-Quarter 2025 Results
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2025 results on Wed., Nov. 5, 2025, at 1 p.m. London time (8 a.m. Eastern Standard Time). The Company will release its third-quarter 2025 results prior to the call.
The audiocast will be accessible at www.livanova.co...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
LIVN
LISTED
NASDAQ
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its participation in the International Surgical Sleep Society (ISSS) 2025 Annual Meeting in Indianapolis. The Company will present a five-year analysis of the THN-3 randomized control trial (RCT), which studied the use of its aura6000™ System for the treatmen...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
LIVN
LISTED
NASDAQ
LivaNova Appoints Donald Zurbay as a New Director
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced the appointment of Donald (Don) Zurbay to the Company’s Board of Directors, effective today. Zurbay will serve on the Audit and Compliance Committee for the Board.
“LivaNova is pleased to welcome Don to our Board of Directors,” said William Kozy, Chair of the Boa...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
LIVN
LISTED
NASDAQ
LivaNova to Host Investor Day on November 12, 2025
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will host an Investor Day and product showcase on Wed., Nov. 12, 2025, beginning at 9 a.m. EST until approximately 1 p.m. EST in New York City and via webcast. Members of the executive leadership team, including Chief Executive Officer Vladimir Makatsaria...
Themefolio
Profiler
Peergroup
© BusinessWire
22.08.2025
LIVN
LISTED
NASDAQ
LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Vladimir Makatsaria, Chief Executive Officer, and Alex Shvartsburg, Chief Financial Officer, will present a general business update during fireside chats at the two following September healthcare conferences in New York City:
Baird 2025 Global Healthc...
Themefolio
Profiler
Peergroup
© BusinessWire
18.08.2025
LIVN
LISTED
NASDAQ
LivaNova Launches Essenz Perfusion System in China
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it initiated the commercial launch of the Essenz™ Perfusion System in China, the second-largest market for LivaNova heart-lung machines (HLMs) after the United States. The Essenz Perfusion System, which recently received regulatory approval from China’s Natio...
Themefolio
Profiler
Peergroup
© BusinessWire
09.07.2025
LIVN
LISTED
NASDAQ
LivaNova to Announce Second-Quarter 2025 Results
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2025 results on Wed., Aug. 6, 2025, at 1 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its second-quarter 2025 results prior to the call.
The audiocast will be accessible at www.livanova....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
05.06.2025
LIVN
LISTED
NASDAQ
CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced completion of the CORE-VNS study, evaluating comprehensive outcomes of real-world evidence for more than 800 people with epilepsy treated with VNS Therapy™ worldwide. With the clinical study report (CSR) now complete, the final 36-month data further validate...
Themefolio
Profiler
Peergroup
© BusinessWire
05.06.2025
LIVN
LISTED
NASDAQ
LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with drug-resistant epilepsy (DRE) from the CORE-VNS three-year study have been published in Epilepsia1.
Several CORE-VNS study findings were highlighted in the recent article on GTC se...
Themefolio
Profiler
Peergroup
© BusinessWire
04.06.2025
LIVN
LISTED
NASDAQ
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it has initiated the process with the U.S. Centers for Medicare and Medicaid Services (CMS) to seek reconsideration of national Medicare coverage for VNS Therapy™ in unipolar patients with treatment-resistant depression (TRD). The first step in the process fo...
Themefolio
Profiler
Peergroup
© BusinessWire
15.05.2025
LIVN
LISTED
NASDAQ
LivaNova to Present at the Jefferies Global Healthcare Conference
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York. The presentation will take place Thurs., June 5, at 3:10 p.m. Eastern Time.
The discussion will be available to all i...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
LIVN
LISTED
NASDAQ
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2025 and updated full-year 2025 guidance.
Financial Summary and Highlights(1)
First-quarter revenue of $316.9 million increased 7.4% on a reported basis, 8.9% on a constant-currency basis, and 10.4% on an organi...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
LIVN
LISTED
NASDAQ
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced 12-month, top-line data from its OSPREY randomized controlled trial (RCT), evaluating outcomes with the aura6000™ System for the treatment of moderate to severe obstructive sleep apnea (OSA). At 12 months of therapy, the treatment arm responder rate was 65% w...
Themefolio
Profiler
Peergroup
© BusinessWire
26.03.2025
LIVN
LISTED
NASDAQ
LivaNova to Announce First-Quarter 2025 Results
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2025 results on Wednesday, May 7, 2025 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its first-quarter 2025 results prior to the call.
The audiocast will be accessible at www.livanova.com/event...
Themefolio
Profiler
Peergroup
© BusinessWire
25.02.2025
LIVN
LISTED
NASDAQ
LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported fourth-quarter and full-year 2024 results and issued full-year 2025 guidance.
Financial Summary and Highlights(1)
Fourth-quarter revenue of $321.8 million increased 3.8% on a reported basis, 4.7% on a constant-currency basis, and 6.8% on an organic basis...
Themefolio
Profiler
Peergroup
© BusinessWire
21.02.2025
LIVN
LISTED
NASDAQ
LivaNova to Present at the Barclays Global Healthcare Conference
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Barclays Global Healthcare Conference in Miami, Florida. The presentation will take place at 2:00 p.m. Eastern Time on Tuesday, March 11.
The discussion will be available to...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2025
LIVN
LISTED
NASDAQ
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2024 results on Tuesday, February 25, 2025 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-quarter and full-year 2024 results prior to the call.
The audiocast will be a...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2025
LIVN
LISTED
NASDAQ
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Natalia Kozmina is joining the Company as Chief Human Resources Officer (CHRO), effective January 14. Kozmina will lead global human resources, serve on the Executive Leadership Team, and report to Vladimir Makatsaria, Chief Executive Officer.
“Natalia...
Themefolio
Profiler
Peergroup
© BusinessWire
18.12.2024
LIVN
LISTED
NASDAQ
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Brain Stimulation has published two pivotal articles chronicling the unipolar cohort data set for the RECOVER clinical study. The researchers evaluated the safety and efficacy of LivaNova’s VNS Therapy™ System and its effectiveness on quality...
Themefolio
Profiler
Peergroup
© BusinessWire
05.12.2024
LIVN
LISTED
NASDAQ
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its participation in the American Epilepsy Society (AES) 2024 Annual Meeting, taking place December 6-10 in Los Angeles. The Company’s therapies and technologies for drug-resistant epilepsy treatment will be featured in numerous scientific posters to support...
Themefolio
Profiler
Peergroup
© BusinessWire
14.11.2024
LIVN
LISTED
NASDAQ
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present a general business update during fireside chats at the three following healthcare conferences in New York in November and December:
Stifel Healthcare Conference 2024 on Tuesday, November 19 from 11...
Themefolio
Profiler
Peergroup
© BusinessWire
11.11.2024
LIVN
LISTED
NASDAQ
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that it met the primary endpoints for its OSPREY randomized controlled trial (RCT), Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation. Together with its safety endpoints, the RCT achieved statistical significance of its primary end...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2024
LIVN
LISTED
NASDAQ
LivaNova Reports Third-Quarter 2024 Results
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended September 30, 2024 and raised full-year 2024 guidance.
Financial Summary and Highlights(1)
Third-quarter revenue of $318.1 million increased 11.2% on both a reported and constant-currency basis, as compared to the prior-year pe...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2024
LIVN
LISTED
NASDAQ
LivaNova Appoints Susan Podlogar as a New Director
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced its Board of Directors has appointed Susan Podlogar to the Board, effective today. Podlogar will serve on the Compensation and Human Capital Management Committee for the Board.
“LivaNova’s Board of Directors is pleased to welcome Susan Podlogar,” said William Kozy...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2024
LIVN
LISTED
NASDAQ
LivaNova to Announce Third-Quarter 2024 Results
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2024 results on Wednesday, October 30, 2024 at 12 p.m. London time (8 a.m. Eastern Time). The Company will release its third-quarter 2024 results prior to the call.
A live audiocast will be accessible at www.livanova....
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2024
LIVN
LISTED
NASDAQ
LivaNova to Present at the Baird Global Healthcare Conference
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Baird 2024 Global Healthcare Conference in New York. The presentation will take place at 10:15 a.m. Eastern Time on Tuesday, September 10.
The discussion will be available...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
